---
title: "FibroBiologics, Inc. (FBLG.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/FBLG.US.md"
symbol: "FBLG.US"
name: "FibroBiologics, Inc."
industry: "Biotechnology"
---

# FibroBiologics, Inc. (FBLG.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [fibrobiologics.com](https://fibrobiologics.com) |

## Company Profile

FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases, including wound healing, multiple sclerosis, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applic...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.91 | 179/603 | - | - | - |
| PB | 134.64 | 436/603 | 131.98 | 23.74 | 12.84 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-08T05:00:00.000Z

Total Analysts: **4**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 2 | 50% |
| Overweight | 1 | 25% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.27 |
| Highest Target | 15.00 |
| Lowest Target | 1.50 |

## References

- [Company Overview](https://longbridge.com/en/quote/FBLG.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/FBLG.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/FBLG.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.